Transactions

All Transactions

We execute various transactions that vary in type, size, and structure. Explore them here.

Prostatype Genomics

Gemstone acted as financial advisor in Prostatype Genomics’ warrant exercise

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test Prostatype®. Prostatype® is a genetic test that provides a comprehensive assessment of the aggressiveness of prostate cancer.

Prostatype Genomics

Gemstone acts as financial advisor in Prostatype Genomics’ Unit Rights Issue

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s warrant exercise

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

Tendo AB

Gemstone was financial advisor and sole bookrunner in Tendo’s rights issue

Tendo has developed a medical device called OneGrip that helps the user to grasp, hold and release objects. The target patient group is people with impaired hand function resulting from a spinal cord injury.

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s rights issue

Qlife has developed and patented the Egoo Health test platform, which integrates several technologies that potentially can test for a wide range of biomarkers and viruses – protein-based and molecular.

Odico A/S

Odico A/S carried out a rights issue up to 13.8 MDKK

In the past decade, Odico has pioneered multiple technologies and products aimed at digitizing and automating the construction industry. This journey of exploration and refinement has transitioned into a promising phase of commercial scale-up, driven by a new management and a strategic partnership model

DecideAct A/S

Gemstone acted as finacial advisor in DecideAct’s rights issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s convertible loan of 5 mDKK

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Rights Issue

A rights issue allows existing owners of a company priority to invest further in the company, if desired.

Prostatype Genomics

Gemstone acts as financial advisor in Prostatype Genomics’ Unit Rights Issue

Tendo AB

Gemstone was financial advisor and sole bookrunner in Tendo’s rights issue

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s rights issue

Odico A/S

Odico A/S carried out a rights issue up to 13.8 MDKK

DecideAct A/S

Gemstone acted as finacial advisor in DecideAct’s rights issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Sound Dimension AB

Gemstone was financial advisor in Sound Dimension’s unit rights issue

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s Unit Rights Issue

Brain+ A/S

Gemstone acted as financial advisor in Brain+’s unit rights issue

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.

Spermosens AB

Gemstone acted as joint financial advisor and joint bookrunner in Spermonsens’ rights issue

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.

Directed Issue

In a directed issue, the existing owners’ pre-emptive right to subscribe for shares is waived, making it typically faster to implement than a rights issue.

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s directed issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Realfiction Holding AB

Gemstone acted as the Danish advisor for Realfiction in their directed issue

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.

Stenocare A/S

Gemstone acted as financial advisor for Stenocare in a Private Placement

IPO

When preparing for a listing, a company may seek to raise capital for growth and diversify ownership among shareholders, often opting to conduct an IPO (Initial Public Offering).

Brain+ A/S

Gemstone Capital acted as financial advisor for Brain+ in their IPO

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.

Sound Dimension AB

Gemstone Capital acted as financial advisor for Sound Dimension in their IPO

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Spermosens AB

Gemstone acted as financial advisor for Spermosens in their IPO

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.

DecideAct A/S

Gemstone acted financial advisor for DecideAct in their IPO

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s IPO

Risk Intelligence A/S

Gemstone acted as financial advisor in Risk Intelligence’s IPO

Risk Intelligence was founded in 2001 by Hans Tino Hansen. The company has evolved into becoming a prominent company in security risk management by delivering threat and risk assessments globally.

Freetrailer Group A/S

Gemstone acted as Financial advisor to Freetrailer in their IPO

Freetrailer has developed a digital platform that uses the Freelock electronic lock in combination with an combination with an application makes it possible to reserve, collect and return a trailer.

Omnicar Holding AB

Gemstone was financial advisor for Omnicar in their IPO

OmniCar has developed a software solution for the car industry. The solution is developed for Citroën in Scandinavia and has been developed by OMI A/S (‘OMI’), a digital marketing agency started by OmniCar co-founder and board member Claus T. Hansen. OmniCar is a spin-off from OMI.

Realfiction Holding AB

Gemstone was financial advisor for Realfiction in their IPO

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.

Warrant Exercise

Companies can issue warrants, which grant investors and employees the opportunity to subscribe to new shares at a potentially favorable price later.

Prostatype Genomics

Gemstone acted as financial advisor in Prostatype Genomics’ warrant exercise

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s warrant exercise

M&A

Transactions involving mergers and acquisitions (M&A), encompassing the purchase and sale of companies.

There is not any transactions within this category

Debt Financing

Capital can be raised through debt, with transactions such as convertible loans and bridge loans being common methods.

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s convertible loan of 5 mDKK

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Sound Dimension AB

Sound Dimension secures a bridge loan of 1.2 MSEK

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Transactions

All Transactions

Prostatype Genomics

Gemstone acted as financial advisor in Prostatype Genomics’ warrant exercise

Prostatype Genomics

Gemstone acts as financial advisor in Prostatype Genomics’ Unit Rights Issue

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s warrant exercise

Tendo AB

Gemstone was financial advisor and sole bookrunner in Tendo’s rights issue

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s rights issue

Odico A/S

Odico A/S carried out a rights issue up to 13.8 MDKK

DecideAct A/S

Gemstone acted as finacial advisor in DecideAct’s rights issue

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s convertible loan of 5 mDKK

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Rights Issue

Prostatype Genomics

Gemstone acts as financial advisor in Prostatype Genomics’ Unit Rights Issue

Tendo AB

Gemstone was financial advisor and sole bookrunner in Tendo’s rights issue

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s rights issue

Odico A/S

Odico A/S carried out a rights issue up to 13.8 MDKK

DecideAct A/S

Gemstone acted as finacial advisor in DecideAct’s rights issue

Sound Dimension AB

Gemstone was financial advisor in Sound Dimension’s unit rights issue

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s Unit Rights Issue

Brain+ A/S

Gemstone acted as financial advisor in Brain+’s unit rights issue

Spermosens AB

Gemstone acted as joint financial advisor and joint bookrunner in Spermonsens’ rights issue

Directed Issue

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s directed issue

Realfiction Holding AB

Gemstone acted as the Danish advisor for Realfiction in their directed issue

Stenocare A/S

Gemstone acted as financial advisor for Stenocare in a Private Placement

IPO

Brain+ A/S

Gemstone Capital acted as financial advisor for Brain+ in their IPO

Sound Dimension AB

Gemstone Capital acted as financial advisor for Sound Dimension in their IPO

Spermosens AB

Gemstone acted as financial advisor for Spermosens in their IPO

DecideAct A/S

Gemstone acted financial advisor for DecideAct in their IPO

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s IPO

Risk Intelligence A/S

Gemstone acted as financial advisor in Risk Intelligence’s IPO

Freetrailer Group A/S

Gemstone acted as Financial advisor to Freetrailer in their IPO

Omnicar Holding AB

Gemstone was financial advisor for Omnicar in their IPO

Realfiction Holding AB

Gemstone was financial advisor for Realfiction in their IPO

Warrant Exercise

Prostatype Genomics

Gemstone acted as financial advisor in Prostatype Genomics’ warrant exercise

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s warrant exercise

M&A

Debt Financing

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s convertible loan of 5 mDKK

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Sound Dimension AB

Sound Dimension secures a bridge loan of 1.2 MSEK

Stenocare A/S

Gemstone act as financial advisor in Stenocares establishment of a convertible loan facility